FDA Inspection 989105 — Merck & Co. Inc

Merck & Co. Inc — FEI 2211017

The FDA completed an inspection of Merck & Co. Inc on Aug 26, 2016 in Rahway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 26, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rahway, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance
748221 CFR 312.50General responsibilities of sponsors
755721 CFR 312.56(b)Notification of FDA of termination of investigator

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.